Tissue plasminogen activator (t-PA) and plasminogen activator inhibitor-1(PAI-1) in children with ulcerative colitis;Tkankowy aktywator plazminogenu (t-PA) i inhibitor tkankowego aktywatora plazminogenu (PAI-1) u dzieci chorych na wrzodzieja̧ce zapalenie jelita grubego

Polski Merkuriusz Lekarski

Volumn 20, Issue 117, 2006, Pages 326-328

  Grabarczyk, Ewa ^a,b   Szaflarska Popławska, Anna ^b,c   Góralczyk, Krzysztof ^a,b   Rość, Danuta ^a,b  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^b NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^c Department of Pediatrics Allergology and Gastroenterology   (Poland)

Author keywords

Children; Plasminogen activator inhibitor 1(PAI 1) ulcerative colitis; Tissue plasminogen activator (t PA)

Indexed keywords

CITRATE SODIUM; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR;

ADOLESCENT; ADULT; ARTICLE; CELIAC DISEASE; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMOSTASIS; HUMAN; INFLAMMATION; MALE; PATHOGENESIS; SCHOOL CHILD; ULCERATIVE COLITIS;

ADOLESCENT; CHILD; COLITIS, ULCERATIVE; FEMALE; FIBRINOLYSIS; HUMANS; MALE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; TISSUE PLASMINOGEN ACTIVATOR;

EID: 33645687693     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Barnahard M.I., Riddle J.M.: Cellular localization of profibrinolytic plasminogen. Blood, 1993, 21, 306-309.
2. Darien B.J., Stone W. C., Dubielziny R.R.: Morphologic changes of the ascending colon during experimental ischaemia and reperfusion in ponies. Vet. Pathol., 1995, 32, 280-288.
3. Doe W.F., Dorsman B.: Chronic inflammatory bowel increased plasminogen activator secretion by mononuclear phagocytes. Clin. Exp. Immunol., 1982, 48, 256-260.
4. Grabarczyk E., Wodyńska T., Kotschy M: Parametry układu fbrynolizy: kompleksy plazmina- alfa 2antyplazmina oraz d- dimery w ostrych zespołach wieńcowych bez uniesienia odcinka ST. Pol. Merk. Lek., 2004, 17, 555-557.
5. Gris J.C., Schved J. F. Raffanel C., Dubois A. i wsp: Impaired fibrinolytic capacity in patients with inflammatory bowel disease. Thromb. Haemost., 1990, 63, 472-475.
6. Huber K., Resch I., Schuster E. i wsp.: Circadian fluctuations of plasminogen activator inhibitor and tissue plasminogen activator levels in plasma of patients with unstable coronary artery disease and acute myocardial infarction. Thromb. Haemost., 1888, 60, 372-375.
7. Jong E., Porte R.J., Knot E.A. i wsp.: Disturbed fibrinolysis in patients with inflammatory bowel disease. A study in blood plasma, colon mucosa, and faeces. Gut., 1989, 30, 188-194.
8. Kurose I., Miura S., Suematsu M. i wsp.: Tissue - type plasminogen activator of colonic mucosa in ulcerative colitis. Evidence of endothelium - fibrinolytic activation. Dig. Dis. Sci., 1992, 37, 307-311.
9. Miseljic S., Galandiuk S., Myers S.D.: Expression of urokinase - type plasminogen activator and plasminogen activator inhibitor in colon disease. J. Clin. Lab. Anal., 1995, 9, 413-417.
10. More L., Sim R., Hudson M. i wsp.: Immunohistochemical study of tissue factor expression in normal intestine and idiopathic inflammatory bowel disease. J. Clin. Pathol., 1993, 46, 703-708.
11. Naitoh H., Eguchi Y., Ueyama H. i wsp.: Localization of urokinase - type plasminogen activator, plasminogen activator inhibitor -2, and plasminogen in colon cancer. Jpn. J. Res., 1995, 86, 48-56.
12. Seitz R., Leugner F., Katschinski M. i wsp.: Ulcerative colitis and Crohn's disease: factor XIII, inflammation and haemostasis. Digestion, 1994, 55, 361-367.
13. Souto J.C., Martinez E., Roca M. i wsp.: Low levels of plasminogen activator inhibitor type 1 in patients with inflammatory bowel disease. Fibrinolysis, 1994, 8, 359-363.
14. Stentz F.B., Umpiemez G.E. Cuervo R. C.i wsp.: Proinflammatory cytokines, markers of cardiovascular risks, oxidative stress, and lipid peroxidation in patiens with hyperglycemic crises. Diabetes, 2004, 53, 8, 2079-2087.
15. Verhaar M.J., Damen D.A.: In vitro a regulation of carcinoembryonic antigen expression by combinations of cytokines. Cancer Lett., 1999, 139, 67-73.
16. De Vries T.J., Van Muijen G.N.P., Ruiter D. i wsp.: The plasminogen activation system in tumor invasion and metastasis. Path. Res. Pract., 1996, 192, 718-733.
17. Vrij A.A., Rijken J. van Wersch J.W., Stockbrugger R.W.: Coagulation and fibrinolysis in inflammatory bowel disease and giant cell arteritis. Pathophysiol. Haemost. Thromb., 2003, 33, 75-83.
18. Wakefield A., Cohen Z., Levy G.: Procoagulant activity in gastroenterology. Gut., 1990, 31, 239-241.